rasa1 -related arteriovenous malformation is driven by aberrant venous signalling
Development · 2023
DOI: 10.1242/dev.201820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Development, 2023. Verfasst von Jasper Greysson-Wong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Alberta Children's Hospital Research Institute, University of Calgary, 3330 University Drive NW, Calgary, AB T2N 4N1, Canada. Hauptthemen laut MEDLINE: Arteriovenous Malformations, Zebrafish Proteins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: CIHR, Cumming School of Medicine, University of Calgary, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Arteriovenous malformations (AVMs) develop where abnormal endothelial signalling allows direct connections between arteries and veins. Mutations in RASA1, a Ras GTPase activating protein, lead to AVMs in humans and, as we show, in zebrafish rasa1 mutants. rasa1 mutants develop cavernous AVMs that subsume part of the dorsal aorta and multiple veins in the caudal venous plexus (CVP) – a venous vascular bed. The AVMs progressively enlarge and fill with slow-flowing blood. We show that the AVM results in both higher minimum and maximum flow velocities, resulting in increased pulsatility in the aorta and decreased pulsatility in the vein. These hemodynamic changes correlate with reduced expression of the flow-responsive transcription factor klf2a. Remodelling of the CVP is impaired with an excess of intraluminal pillars, which is a sign of incomplete intussusceptive angiogenesis. Mechanistically, we show that the AVM arises from ectopic activation of MEK/ERK in the vein of rasa1 mutants, and that cell size is also increased in the vein. Blocking MEK/ERK signalling prevents AVM initiation in mutants. Alterations in venous MEK/ERK therefore drive the initiation of rasa1 AVMs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Alberta Children's Hospital Research Institute, University of Calgary, 3330 University Drive NW, Calgary, AB T2N 4N1, Canada.
- Department of Biochemistry and Molecular Biology, University of Calgary, 3330 University Drive NW, Calgary, AB T2N 4N1, Canada.
- Department of Chemical and Petroleum Engineering, University of Calgary, 3330 University Drive NW, Calgary, AB T2N 4N1, Canada.
ORCID-Profile: Jasper Greysson-Wong, Jae-Ryeon Ryu, Kristina D Rinker, Sarah J Childs
Förderung
- CIHR
- Cumming School of Medicine, University of Calgary
- Canadian Institutes of Health Research
- Heart and Stroke Foundation of Canada
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Greysson-Wong, J., Rode, R., Ryu, J. R., Chan, J. L., Davari, P., Rinker, K. D., & Childs, S. J. (2023). rasa1 -related arteriovenous malformation is driven by aberrant venous signalling. Development. https://doi.org/10.1242/dev.201820
Vancouver
Greysson-Wong J, Rode R, Ryu JR, Chan JL, Davari P, Rinker KD, et al. rasa1 -related arteriovenous malformation is driven by aberrant venous signalling. Development. 2023. doi:10.1242/dev.201820
BibTeX
@article{GreyssonWong2023,
author = {Greysson-Wong, Jasper and Rode, Rachael and Ryu, Jae-Ryeon and Chan, Jo Li and Davari, Paniz and Rinker, Kristina D and Childs, Sarah J},
title = {rasa1 -related arteriovenous malformation is driven by aberrant venous signalling},
journal = {Development},
year = {2023},
doi = {10.1242/dev.201820}
}
EUVIMED